Automate Your Wheel Strategy on CVS
With Tiblio's Option Bot, you can configure your own wheel strategy including CVS - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol CVS
- Rev/Share 310.5469
- Book/Share 57.6123
- PB 1.3983
- Debt/Equity 1.121
- CurrentRatio 0.8319
- ROIC 0.0043
- MktCap 102011594495.0
- FreeCF/Share 4.959
- PFCF 16.2103
- PE 217.4346
- Debt/Assets 0.3202
- DivYield 0.0331
- ROE 0.0062
- Rating B+
- Score 3
- Recommendation Neutral
- P/E Score 1
- DCF Score 5
- P/B Score 4
- D/E Score 1
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Initiation | CVS | Goldman | -- | Buy | -- | $91 | Oct. 14, 2025 |
| Upgrade | CVS | UBS | Neutral | Buy | -- | $79 | Aug. 18, 2025 |
| Upgrade | CVS | Robert W. Baird | Neutral | Outperform | -- | $82 | Aug. 14, 2025 |
| Upgrade | CVS | Leerink Partners | Market Perform | Outperform | $55 | $75 | Feb. 13, 2025 |
| Upgrade | CVS | Cantor Fitzgerald | Neutral | Overweight | -- | -- | Feb. 12, 2025 |
| Upgrade | CVS | Edward Jones | Hold | Buy | -- | -- | Jan. 30, 2025 |
| Upgrade | CVS | Deutsche Bank | Hold | Buy | -- | $66 | Dec. 3, 2024 |
| Upgrade | CVS | Barclays | Equal Weight | Overweight | $63 | $82 | Oct. 10, 2024 |
| Upgrade | CVS | TD Cowen | Hold | Buy | $59 | $85 | Oct. 4, 2024 |
News
CVS drops Lilly's Zepbound
Published: July 01, 2025 by: CNBC Television
Sentiment: Negative
CNBC's Angelica Peebles reports on news regarding CVS.
Read More
These are the best-performing stocks of H1 2025
Published: July 01, 2025 by: Finbold
Sentiment: Positive
With the first half of 2025 now behind us, the stock market has seen its share of volatility.
Read More
Will CVS Health's Formulary Move Boost Its Weight Management Program? (Revised)
Published: June 30, 2025 by: Zacks Investment Research
Sentiment: Positive
CVS adds Wegovy to its top formularies and bolsters its Weight Management program, aiming to expand access while cutting costs.
Read More
CVS vs. DHR: Which Stock Is the Better Value Option?
Published: June 27, 2025 by: Zacks Investment Research
Sentiment: Neutral
Investors interested in stocks from the Medical Services sector have probably already heard of CVS Health (CVS) and Danaher (DHR). But which of these two stocks offers value investors a better bang for their buck right now?
Read More
Are Medical Stocks Lagging CVS Health (CVS) This Year?
Published: June 27, 2025 by: Zacks Investment Research
Sentiment: Negative
Here is how CVS Health (CVS) and Agenus (AGEN) have performed compared to their sector so far this year.
Read More
CVS Health opens new Workforce Innovation and Talent Center in Chicago
Published: June 26, 2025 by: PRNewsWire
Sentiment: Neutral
The new center is located at the Chicago Baptist Institute CHICAGO , June 26, 2025 /PRNewswire/ -- CVS Health® (NYSE: CVS) announced today the opening of its new Workforce Innovation and Talent Center (WITC) in Chicago. The center, situated at the Chicago Baptist Institute, will improve the community's access to workforce training services and provide every participant who completes the program an opportunity to apply for a position at CVS Health.
Read More
3 High-Yield Dividend Kings Beating the S&P 500 This Year
Published: June 25, 2025 by: 24/7 Wall Street
Sentiment: Positive
The S&P 500 is one of the most widely known benchmarks. It contains the 500 most valuable publicly traded U.S.
Read More
Attorney General Liz Murrill files three lawsuits against CVS for unlawful practices
Published: June 24, 2025 by: Reuters
Sentiment: Negative
Louisiana Attorney General Liz Murrill said on Tuesday that she had filed three separate lawsuits against CVS for unfair, deceptive, and unlawful practices that have harmed Louisiana patients, independent pharmacies, and the public at large.
Read More
Will CVS Health's Formulary Move Boost Its Weight Management Program?
Published: June 24, 2025 by: Zacks Investment Research
Sentiment: Positive
CVS adds Wegovy to its top formularies and bolsters its Weight Management program, aiming to expand access while cutting costs.
Read More
Why CVS Health (CVS) is a Top Value Stock for the Long-Term
Published: June 23, 2025 by: Zacks Investment Research
Sentiment: Positive
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Read More
Aetna Supports Industry Actions to Simplify Prior Authorization
Published: June 23, 2025 by: PRNewsWire
Sentiment: Neutral
Company commits to distinctive actions that will make it easier to navigate the health care system, access care, and achieve better health HARTFORD, Conn. , June 23, 2025 /PRNewswire/ -- Aetna, a CVS Health company (NYSE: CVS), today announced its support of initiatives championed by American's Health Insurance Plans to improve the experience of doctors and patients.
Read More
New June Fortune 500 Industry Leaders Show 3 Ideal "Safer" Dividend Buys
Published: June 20, 2025 by: Seeking Alpha
Sentiment: Positive
Three Fortune 500 Industry Leaders—Energy Transfer, Verizon, and World Kinect—currently meet the 'dogcatcher' ideal of fair price and safer dividends. Analyst targets project 21% to 50% net gains for the top ten F500IL dividend dogs by June 2026, with average gains of 28.8%. Most top-yielding F500IL stocks remain overpriced, but a 60% market correction or dividend increases could make all ten fairly priced for income investors. Twelve F500IL stocks have negative free cash flow margins, making them unsafe for dividends; focus on the three 'safer' fair-priced options for now.
Read More
Investors Heavily Search CVS Health Corporation (CVS): Here is What You Need to Know
Published: June 19, 2025 by: Zacks Investment Research
Sentiment: Positive
CVS Health (CVS) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Read More
Two Healthcare Heavyweights, One Winner: UnitedHealth or CVS Health?
Published: June 18, 2025 by: Zacks Investment Research
Sentiment: Positive
CVS gains steam as rising margins, strong Medicare results, and cost cuts set it apart from UNH.
Read More
Exploring CVS' Health Services Segment: A Key Growth Engine for 2025?
Published: June 18, 2025 by: Zacks Investment Research
Sentiment: Neutral
CVS' Health Services segment posts $43B in revenues as specialty pharmacy and Caremark deals drive 2025 growth prospects.
Read More
5 Low Price-to-Book Value Stocks That You Can Buy in June
Published: June 17, 2025 by: Zacks Investment Research
Sentiment: Positive
The P/B ratio helps to identify low-priced stocks with high growth prospects. USNA, CVS, PFE, STNE and PSFE are some such stocks.
Read More
3 Medical Services Stocks Capitalizing on the Healthcare AI Boom
Published: June 16, 2025 by: Zacks Investment Research
Sentiment: Positive
CVS, BTSG and WGS are three medical services stocks tapping into AI and tech-driven care to boost diagnostics, cut costs and drive growth in 2025.
Read More
4 Value Stocks to Shield Your Portfolio Amid Geopolitical Turmoil
Published: June 16, 2025 by: Zacks Investment Research
Sentiment: Positive
As geopolitical risks jolt markets, STNE, CNC, CVS and PFE shine with low cash flow valuations and solid earnings outlooks.
Read More
CVS Health's MBR Improves: Can It Sustain Amid Elevated Cost Trends?
Published: June 12, 2025 by: Zacks Investment Research
Sentiment: Positive
CVS posts its first favorable MBR in quarters, but elevated cost trends test its ability to sustain the gains.
Read More
CVS vs. DHR: Which Stock Should Value Investors Buy Now?
Published: June 11, 2025 by: Zacks Investment Research
Sentiment: Positive
Investors with an interest in Medical Services stocks have likely encountered both CVS Health (CVS) and Danaher (DHR). But which of these two stocks is more attractive to value investors?
Read More
5 Ideal 'Safe' Buys From June Fortune Return On Leadership Screen
Published: June 10, 2025 by: Seeking Alpha
Sentiment: Positive
Coincident to the June 5, 2025 annual launch of their Fortune 500, Fortune also partnered with Indiggo to measure Return On Leadership, called the ROL100. Arnold research focused on those 100 using YCharts 6/6/25 data on Dividends from 78, which hereafter are referred to as the Fortune Return on Leadership Dividend Dogs (FROLD). ReturnOnLeadership is based on four fundamental factors: Connection to Purpose, Strategic Clarity, Leadership Alignment, and Focused Action.
Read More
CVS Health Advances Digital Strategy: Is It the Next Revenue Pillar?
Published: June 05, 2025 by: Zacks Investment Research
Sentiment: Neutral
CVS unveils a $20B digital strategy to tackle healthcare gaps and reshape consumer health experiences.
Read More
Here is What to Know Beyond Why CVS Health Corporation (CVS) is a Trending Stock
Published: June 04, 2025 by: Zacks Investment Research
Sentiment: Positive
CVS Health (CVS) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Read More
Top 4 Value Stocks to Buy as Trade Tensions Still Cloud H2 Outlook
Published: June 03, 2025 by: Zacks Investment Research
Sentiment: Positive
STNE, CNC, CVS and PFE stand out as top value picks amid trade tensions and a murky H2 economic outlook.
Read More
CVS Sues Arkansas Over Law Banning PBM Ownership Of Pharmacies
Published: May 29, 2025 by: Forbes
Sentiment: Negative
CVS Health Thursday sued the state of Arkansas, trying to thwart a law the healthcare company said would lead to the closure of all 23 CVS drugstores in the state.
Read More
5 Valuable Price-to-Book Stocks to Strengthen Your Portfolio
Published: May 29, 2025 by: Zacks Investment Research
Sentiment: Positive
The P/B ratio helps to identify low-priced stocks with high growth prospects. CNC, CVS, PFE, STNE and PSFE are some such stocks.
Read More
CVS or DHR: Which Is the Better Value Stock Right Now?
Published: May 26, 2025 by: Zacks Investment Research
Sentiment: Positive
Investors interested in stocks from the Medical Services sector have probably already heard of CVS Health (CVS) and Danaher (DHR). But which of these two stocks is more attractive to value investors?
Read More
Avoid These Dividend Disasters Before It's Too Late
Published: May 23, 2025 by: Seeking Alpha
Sentiment: Negative
Dividend stocks are facing many big risks. The high interest rates, trade war, and AI revolution could lead to many dividend cuts. I discuss what this all means for dividend investors.
Read More
Wall Street Bulls Look Optimistic About CVS Health (CVS): Should You Buy?
Published: May 22, 2025 by: Zacks Investment Research
Sentiment: Positive
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?
Read More
UnitedHealth, CVS Health And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
Published: May 22, 2025 by: Benzinga
Sentiment: Negative
U.S. stock futures were mixed this morning, with the Nasdaq futures gaining around 50 points on Thursday.
Read More
About CVS Health Corporation (CVS)
- IPO Date 1996-11-20
- Website https://www.cvshealth.com
- Industry Medical - Healthcare Plans
- CEO J. David Joyner CEBS
- Employees 219000